[The role of anti-neutrophil cytoplasmic antibodies (ANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA) in inflammatory bowel disease].
Gisbert
J P
JP
Servicio de Aparato Digestivo. Hospital Universitario de la Princesa. Madrid. Spain. gisbert@meditex.es
Gomollón
F
F
Maté
J
J
Pajares
J M
JM
D019268:Antibodies, Antineutrophil Cytoplasmic / Q000032:analysis / Q000276:immunology*; D000908:Antibodies, Fungal / Q000032:analysis / Q000276:immunology*; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000235:genetics / Q000276:immunology*; D015415:Biomarkers; D003092:Colitis / Q000175:diagnosis / Q000276:immunology; D003093:Colitis, Ulcerative / Q000175:diagnosis / Q000235:genetics / Q000276:immunology / Q000601:surgery; D039021:Colonic Pouches; D003424:Crohn Disease / Q000175:diagnosis / Q000235:genetics / Q000276:immunology; D020022:Genetic Predisposition to Disease; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000175:diagnosis / Q000235:genetics / Q000276:immunology*; D010641:Phenotype; D011183:Postoperative Complications; D015995:Prevalence; D016737:Proctocolectomy, Restorative; D011379:Prognosis; D012306:Risk; D012441:Saccharomyces cerevisiae / Q000276:immunology*; D012680:Sensitivity and Specificity
D019268:Antibodies, Antineutrophil Cytoplasmic; D000908:Antibodies, Fungal; D015415:Biomarkers